The Italy Peptide Receptor Radionuclide Therapy (PRRT) Market was valued at US$ 3.6 million in 2019, and is expected to witness a CAGR of 9.2%over the forecast period (2019 – 2027).
Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027
Source: Coherent Market Insights Analysis (2019)
Market- TrendsIncreasing incidence of pancreatic cancer, as well as availability of reimbursement for cancer drug is another factor contributing to the market growth.
Increasing incidence of pancreatic cancer in Europe region is expected to support growth of the market over the forecast period. For instance, according to United European Gastroenterology report in Europe region, there was a 5% increase in the number of pancreatic cancer cases during the years 1990 to 2016.
Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients